Full Text View
Tabular View
No Study Results Posted
Related Studies
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
This study has been terminated.
( low accrual )
Study NCT00062231   Information provided by European Organisation for Research and Treatment of Cancer - EORTC

First Received on June 5, 2003.   Last Updated on September 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fever, Sweats, and Hot Flashes
Infection
Leukemia
Lymphoma
Myelodysplastic Syndromes
Neutropenia
Precancerous Condition
Additional conditions recognized in this trial
Fever
Hot Flashes
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Multiple Myeloma
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms, Plasma Cell
Plasmacytoma
Precancerous Conditions
Preleukemia
More general conditions related to this trial
Agranulocytosis
Blood Protein Disorders
Body Temperature Changes
Bone Marrow Diseases
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Leukocyte Disorders
Leukopenia
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
amoxicillin-clavulanate potassium
ciprofloxacin
moxifloxacin hydrochloride
management of therapy complications
Additional drug interventions recognized in this trial
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Clavulanic Acids
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
European Organisation for Research and Treatment of Cancer - EORTC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services